CKD Treatment: Time to Alter the Focus to Albuminuria?

Advances in Chronic Kidney Disease

Volumn 18, Issue 4, 2011, Pages 222-223

  de Zeeuw, Dick ^a   Parekh, Rulan ^b   Soman, Sandeep ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN INHIBITOR;

AGING; ALBUMINURIA; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CLINICAL PRACTICE; DIABETES MELLITUS; EDITORIAL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM; SEVERITY OF ILLNESS INDEX;

EID: 79960493527     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2011.06.005     Document Type: Editorial

References (5)

1. Stewart J.H., McCredie M.R., Williams S.M., et al. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrology (Carlton) 2007, 12:520-527.
2. Yee J. CKD and hypertension: pogo and pragmatism. Adv Chronic Kidney Dis 2011, 18:1-2.
3. de Zeeuw D. Albuminuria: a target for treatment of type 2 diabetic nephropathy. Semin Nephrol 2007, 27:172-181.
4. Eijkelkamp W.B., Zhang Z., Remuzzi G., et al. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol 2007, 18:1540-1546.
5. Hou F.F., Xie D., Zhang X., et al. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency. J Am Soc Nephrol 2007, 18:1889-1898.